Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-30 Haviland Kate Director Grant or award · Stock Option (right to buy) +32,000 32,000
2025-06-26 Haviland Kate Director Grant or award · Stock Option (right to buy) +36,000 36,000
2024-06-17 Haviland Kate Director Grant or award · Stock Option (right to buy) +30,000 30,000
2023-06-27 Haviland Kate Director Grant or award · Stock Option (right to buy) +30,000 30,000
2022-06-27 Haviland Kate Director Grant or award · Stock Option (right to buy) +19,000 19,000
2021-06-09 Haviland Kate Director Grant or award · Stock Option (right to buy) +15,000 15,000
2020-06-11 Haviland Kate Director Grant or award · Stock Option (right to buy) +9,285 9,285
2019-07-18 Haviland Kate Director Grant or award · Stock Option (right to buy) +9,285 9,285

Page 1 of 1 · 8 trades